Search Results - "Keslova, P"

Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence by Borgmann-Staudt, A, Rendtorff, R, Reinmuth, S, Hohmann, C, Keil, T, Schuster, F R, Holter, W, Ehlert, K, Keslova, P, Lawitschka, A, Jarisch, A, Strauss, G

“…Infertility is a major late effect in patients receiving haematopoietic stem cell transplantation (HSCT). The aim of this study was to determine the proportion…”
Get full text

Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study by Pfitzer, C., Orawa, H., Balcerek, M., Langer, T., Dirksen, U., Keslova, P., Zubarovskaya, N., Schuster, F. R., Jarisch, A., Strauss, G., Borgmann-Staudt, A.

“…Purpose Fertility impairment and recovery after haematopoietic stem cell transplantation (HSCT) have been reported in both sexes, but little is known about how…”
Get full text

Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood by Keslova, P, Formankova, R, Riha, P, Sramkova, L, Snajderova, M, Malinova, B, Luks, A, Sterba, J, Stary, J, Sedlacek, P

“…Allogeneic hematopoietic stem cell transplantation (HSCT) has become a standard part of therapy for a variety of malignant and non-malignant disorders. With…”
Get more information

CMV resistance in patients after allogeneic haematopoietic stem cell transplantation by Hubacek, P, Kouba, M, Boutolleau, D, Pliskova, L, Vejrazkova, E, Keslova, P, Sedlacek, P, Cetkovsky, P

Get full text

The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study by Valkova, V, Jircikova, J, Trnkova, M, Steinerova, K, Keslova, P, Lanska, M, Koristek, Z, Raida, L, Krejci, M, Kruntoradova, K, Dolezal, T, Benesova, K, Cetkovsky, P, Trneny, M

“…Although allogeneic haematopoietic stem cell transplantation (allo-HSCT) offers a unique curative potential, it may be connected with high treatment-related…”
Get more information

PP113—Parenteral busulfan in myeloablative conditioning regimens for hematopoietic stem-cell transplantation (HSCT) in children by Janeckova, D, Sedlacek, P, Tesfaye, H, Riha, P, Keslova, P, Krol, L, Sumerauer, D, Malis, J, Sevec, M, Klapkova, E, Branova, R

Get full text

Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors by Sedlacek, P, Mejstrikova, E, Formankova, R, Keslova, P, Dobrovolna, M, Vrana, M, Stary, J

“…Allogeneic HSCT is a curative treatment for high-risk leukemia. In Europe, approximately 15% of children have an HLA-matched sibling, but in 65–70% HLA…”
Get full text

Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT by Król, L, Stuchlý, J, Hubáček, P, Keslová, P, Sedláček, P, Starý, J, Hrušák, O, Kalina, T

“…Depletion of cellular immunity as a consequence of conditioning before allogeneic hematopoietic SCT (HSCT) frequently results in CMV reactivation, which may in…”
Get full text

Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapy by Mardesic, T, Snajderova, M, Sramkova, L, Keslova, P, Sedlacek, P, Stary, J

“…Infertility represents one of the main sequelae of cytotoxic therapy given for various malignant diseases. Because dividing cells are more sensitive to…”
Get more information

PIX-3 Cytomegalovirus (CMV) resistance to antivirals in children and adult hematopoietic stem cell transplant recipients from the Czech Republic – a two centres experience by Hubacek, P, Boutolleau, D, Deback, C, Hrdlickova, A, Conan, F, Lelabousse, B, Zajac, M, Markova, M, Keslova, P, Agut, H, Sedlacek, P, Cetkovsky, P

Get full text

Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic by Krol, L, Formankova, R, Keslova, P, Vavra, V, Zemanova, Z, Michalova, K, Dobrovolna, M, Moravcova, J, Kobylka, P, Ivaskova, E, Navratilova, J, Stary, J, Sedlacek, P

“…Chronic myeloid leukemia (CML) is a myeloproliferative disorder caused by clonal proliferation of primitive hematopoietic stem cell. The median age at…”
Get more information

Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8 10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin by SEDLACEK, P, FORMANKOVA, R, KESLOVA, P, SRAMKOVA, L, HUBACEK, P, KROL, L, KULICH, M, STARY, J

“…Human leukocyte antigen (HLA)-matched sibling donor hematopoietic stem cell transplantation (HSCT) is available for only approximately 30% patients needing…”
Get full text

Normalised EBV Quantity in Patients After Allogeneic Haematopoietic Stem Cell Transplantation – Benign Reactivation, Localised and Generalised EBV Lymphoproliferative Disease by Hubacek, P, Mejstrikova, E, Markova, M, Kouba, M, Kabickova, E, Zajac, M, Hornofova, L, Keslova, P, Sedlacek, P, Cetkovsky, P

Get full text

CMV resistance in patients after allogeneic haematopoietic stem cell transplantation: Presentation at ESCV 2015: Poster 2 by Hubacek, P, Kouba, M, Boutolleau, D, Pliskova, L, Vejrazkova, E, Keslova, P, Sedlacek, P, Cetkovsky, P

Get full text

Is serological or PCR positivity of Toxoplasma gondii in donor or recipient the reason for haematopoietic stem cell transplantation delay? by Krol, L, Matulova, M, Hubacek, P, Keslova, P, Formankova, R, Sedlacek, P

“…T. gondii is obligate intracellular parasite causing infection known as toxoplasmosis. In immunocompetent host it causes an asymptomatic infection or fever…”
Get full text

Rituximab is effective in refractory autoimmune hemolytic anaemia following allogeneic haematopoietic stem cell transplantation by Formankova, R, Sedlacek, P, Keslova, P, Mejstrikova, E, Pisacka, M, Linhartova, E, Zizkova, H, Stary, J

“…Autoimmune hemolytic anemia (AIHA) is a recognized complication of allogeneic stem cell transplantation (SCT). Between I/2000 and VI/2008 214 children…”
Get full text

Normalised EBV quantity in patients after allogeneic haematopoietic stem cell transplantation--benign reactivation, localised and generalised EBV lymphoproliferative disease by Hubacek, P, Hrdlickova, A, Mejstrikova, E, Valkova, V, Kabickova, E, Capkova, L, Keslova, P, Formankova, R

“…EBV remains important pathogen in patients after haematopoietic stem cell transplantation (HSCT). Beside benign reactivation, EBV can cause localised or…”
Get full text

EBV quantification in children after allogeneic hematopoietic stem cell transplantation by Hubácek, P, Cinek, O, Kulich, M, Zajac, M, Keslová, P, Formánková, R, Starý, J, Sedlácek, P

“…Patients undergoing allogeneic hematopoietic stem cell transplantation (AHSCT) are endangered by developing Epstein-Barr virus-related post-transplant…”
Get more information